Sacubitril/Valsartan Shows No Superiority Over Enalapril in Pediatric HF, Study Finds Dr. Prem Aggarwal3 Oct 2024 9:00 AM ISTResearchers have established that sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor (ARNI), is not superior to enalapril in the...
Odanacatib safe and efficacious alternative for treatment of osteoporosis among postmenopausal women: Study Dr Riya Dave21 Sept 2024 2:00 AM ISTResearchers have found that odanacatib (ODN), a cathepsin K (CatK) inhibitor, is an effective and safe treatment option for postmenopausal...
Secukinumab may significantly alleviate symptoms of psoriatic arthritis, finds research Dr Riya Dave24 April 2024 7:45 PM ISTResearchers have found that a dose of 300 mg of secukinumab can significantly alleviate symptoms of psoriatic arthritis (PsA) compared to placebo,...
Cariprazine Shows High Tolerability and Completion Rates in Major Depressive Disorder Patients Dr Riya Dave9 Feb 2024 9:00 PM ISTCariprazine, approved by the FDA as an adjunctive treatment for MDD, has demonstrated positive outcomes in various trials. The analysis focused on its...
Extended use of inclisiran safe and efficacious among refractory dyslipidemia in patients with increased CV risk Dr Riya Dave29 Dec 2023 8:45 PM ISTA recent study sheds light on the safety profile of inclisiran, an innovative agent designed to reduce low-density lipoprotein cholesterol (LDL-C)....
Aspirin use may significantly delay progression of Abdominal Aortic Aneurysm with favorable safety profile. Aditi15 Dec 2023 9:45 AM ISTThe preclinical research indicates that aspirin may play a role in slowing the progression of abdominal aortic aneurysms (AAAs) and averting their...
Extra-Strength Jeuveau achieves positive outcomes for treatment of glabellar lines in adults for up to 6 months Dr Riya Dave11 Nov 2023 9:15 AM ISTEvolus, Inc. recently revealed results from a Phase 2 clinical study showcasing the efficacy of the "extra-strength" 40U dose of Jeuveau in extending...
Safety and Efficacy of Vildagliptin 100mg SR- Ft. Prof. Dr Aravinda Jagadeesha Dr. Nandita Mohan15 Dec 2022 11:17 AM IST Among the gliptins, vildagliptin is the only therapy requiring twice-daily dosing and thus adversely impacts patient adherence. To reduce dosing...
Erenumab effective in patients with migraine: JAMA Dr. Shravani Dali27 Dec 2021 9:00 AM ISTErenumab treatment in patients with migraine with and without a history of aura is effective, according to a new study published in the JAMA ...
Adalimumab efficacious in conjunction with Surgery in Hidradenitis Suppurativa: Study Dr. Shravani Dali20 Dec 2021 9:00 AM ISTAdalimumab was efficacious in conjunction with Surgery in moderate to severe Hidradenitis Suppurativa, according to a recent study published in the...
Systematic screening for AF tied to lower morbidity and mortality in elderly: Lancet Dr. Shravani Dali12 Nov 2021 9:00 AM ISTScreening for atrial fibrillation is safe and beneficial in older populations, according to a recent study published in the Lancet.Systematic...
Eplerenone reduces urinary Albumin creatinine ratio in diabetics at high risk of CVD: Study Dr. Shravani Dali18 Oct 2021 9:00 AM ISTEplerenone improves Albumin Excretion in type 2 diabetes (T2D) With Acceptable Safety, suggests a study published in the Diabetes and Metabolism.As...
